- Home
- ROIV vs EAT Comparison
ROIV vs EAT Comparison
Compare ROIV & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- EAT
- Stock Information
- Founded
- ROIV 2014
- EAT 1975
- Country
- ROIV United Kingdom
- EAT United States
- Employees
- ROIV N/A
- EAT N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- EAT Restaurants
- Sector
- ROIV Health Care
- EAT Consumer Discretionary
- Exchange
- ROIV Nasdaq
- EAT Nasdaq
- Market Cap
- ROIV 8.4B
- EAT 7.0B
- IPO Year
- ROIV N/A
- EAT N/A
- Fundamental
- Price
- ROIV $10.64
- EAT $137.01
- Analyst Decision
- ROIV Buy
- EAT Hold
- Analyst Count
- ROIV 4
- EAT 16
- Target Price
- ROIV $17.50
- EAT $144.36
- AVG Volume (30 Days)
- ROIV 6.2M
- EAT 1.9M
- Earning Date
- ROIV 05-29-2025
- EAT 04-29-2025
- Dividend Yield
- ROIV N/A
- EAT N/A
- EPS Growth
- ROIV N/A
- EAT 113.08
- EPS
- ROIV N/A
- EAT 7.16
- Revenue
- ROIV $122,585,000.00
- EAT $5,130,500,000.00
- Revenue This Year
- ROIV N/A
- EAT $19.93
- Revenue Next Year
- ROIV N/A
- EAT $4.61
- P/E Ratio
- ROIV N/A
- EAT $19.16
- Revenue Growth
- ROIV 140.04
- EAT 19.80
- 52 Week Low
- ROIV $8.73
- EAT $56.27
- 52 Week High
- ROIV $13.06
- EAT $192.22
- Technical
- Relative Strength Index (RSI)
- ROIV 47.30
- EAT 44.72
- Support Level
- ROIV $11.02
- EAT $125.78
- Resistance Level
- ROIV $11.77
- EAT $140.51
- Average True Range (ATR)
- ROIV 0.33
- EAT 6.10
- MACD
- ROIV -0.02
- EAT -1.11
- Stochastic Oscillator
- ROIV 28.93
- EAT 28.39
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About EAT Brinker International Inc.
Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.